Mohit Manrao

Oncology
ASCO Mohit Manrao feature

ASCO 2024 - Mohit Manrao

Just about everyone seems to agree that the runaway success story of ASCO this year is AstraZeneca, with plenary sessions for the sixth year in a row and

R&D
What’s next for oncology research?

What’s next for oncology research?

Eliminating cancer as a cause of death is a highly ambitious goal, but oncology researchers are showing no signs of giving up the fight in 2023.